Yuji Minegishi

5PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 27, 2026
Efficacy and safety of necitumumab and pembrolizumab combination therapy in advanced non-small-cell lung cancer with ≥50% PD-L1 expression: A nonrandomized phase II trial.

|May 03, 2024
Acute exacerbation predicting poor outcomes in idiopathic interstitial pneumonia and advanced lung cancer patients undergoing cytotoxic chemotherapy.

Atsushi Miyamoto, Hirofumi Michimae, Yasuharu Nakahara

|Apr 01, 2022
Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial.

Kohei Otsubo, Junji Kishimoto, Masahiko Ando

|Mar 02, 2021
A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027.

Yuji Minegishi, Ou Yamaguchi, Shunichi Sugawara

|Jun 05, 2020
Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan.

Yuji Minegishi, Akihiko Gemma, Sakae Homma

Pageof 1

Frequent Collaborators

1 joint publications

Arata Azuma

1 joint publications

Kiminobu Tanizawa

1 joint publications

Yoshikazu Inoue

1 joint publications

Kohei Otsubo